Close Menu

single-cell genomics

Fluidigm said this week that single-cell genomics applications and production genotyping continued to serve as the primary growth drivers for the company, helping first-quarter revenues spike 33 percent year over year.

SINGAPORE — A new center located in this Asian city-state should expand regional single-cell biology research efforts and aid in the development of new diagnostics and therapies, according to its founders.

By encapsulating single organisms from microbiome samples in gel microdroplets and then culturing them to form microcolonies, researchers from the Los Alamos National Laboratory have been able to sequence the genomes of individual bacterial species with much higher coverage and l

Star Array, a spinout of Singapore's Nanyang Technological University, has developed a microfluidic liquid-phase nucleic acid purification chip that can selectively isolate DNA or RNA from low numbers of cells in minute sample volumes, and subsequently PCR amplify the purified nu

Fluidigm has released a system and protocols to automate the processing of cells for single-cell transcriptome sequencing.

NEW YORK (GenomeWeb News) – The Genome Institute of Singapore and Fluidigm today announced the creation of a single-cell genomics research center.

Fluidigm said this week that single-cell genomics and production genotyping continued to be the most important end markets for its gene expression products, helping to drive a 31 percent increase in product revenues amid an overall 22 percent revenue increase in the second quarte

Fluidigm said today that it has initiated an early-access program for its new C1 Single-Cell AutoPrep System for single-cell gene expression studies.

Fluidigm's product revenues are expected to grow 27 percent annually over the next four years, buoyed by the company's participation in three rapidly growing niche markets — sample preparation for next-gen sequencing, single-cell genomics, and digital PCR — according to a market

This article has been updated from a previous version to include market research information about Fluidigm from DeciBio.

Pages

A small, early-stage trial of a combination therapy for brain cancer reports favorable responses in two patients, according to the Guardian.

Nature News writes that viral genomic surveillance in the US faces systemic issues.

President Joe Biden is seeking an increase in federal spending, including higher budgets for the National Institutes of Health and Centers for Disease Control and Prevention.

In PLOS this week: sex-stratified genome-wide association study of chronic pain, sequencing data from Indigenous Mexican groups, and more.